R. A. Miller
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Health, Toxicology and Mutagenesis top 5%
- Pathology and Forensic Medicine top 10%
- Topics
- Carcinogens and Genotoxicity Assessment (7 papers)Radiopharmaceutical Chemistry and Applications (3 papers)Lymphoma Diagnosis and Treatment (3 papers)
- Partner nations
- United States
In The Last Decade
R. A. Miller
13 papers receiving 923 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 397
- Radiology, Nuclear Medicine and Imaging 357
- Molecular Biology 241
- Health, Toxicology and Mutagenesis 239
- Pathology and Forensic Medicine 197
Countries citing papers authored by R. A. Miller
This map shows the geographic impact of R. A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. A. Miller more than expected).
Fields of papers citing papers by R. A. Miller
This network shows the impact of papers produced by R. A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. A. Miller. The network helps show where R. A. Miller may publish in the future.
Co-authorship network of co-authors of R. A. Miller
This figure shows the co-authorship network connecting the top 25 collaborators of R. A. Miller. A scholar is included among the top collaborators of R. A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. A. Miller. R. A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 10 | |
| 3 | 12 | |
| 4 | 7 | |
| 5 | 56 | |
| 6 | 6 | |
| 7 | Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations. | 205 |
| 8 | Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody. | 56 |
| 9 | 219 | |
| 10 | 1 | |
| 11 | 221 | |
| 12 | 13 | |
| 13 | 181 |
About R. A. Miller
R. A. Miller is a scholar working on Chemical Health and Safety, Cancer Research and Health, Toxicology and Mutagenesis, having authored 13 papers that have together received 995 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (7 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (397 citations), Chemical Health and Safety (17 citations) and Health, Toxicology and Mutagenesis (239 citations). R. A. Miller has collaborated with scholars based in United States. Frequent co-authors include Ronald Levy, J Huff, Billy J. Chou, R L Melnick, J. K. Haseman, Mark B. Powers, C Badger, K. A. Krohn, Janet F. Eary and Paul J. Martin. Their work appears in journals such as Science, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.